| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |